Interventional Treatment of Severe Tricuspid Regurgitation | Zendy

Alexander Lauten | Zendy; Hans R. Figulla | Zendy; Axel Unbehaun | Zendy; Neil Fam | Zendy; Joachim Schöfer | Zendy; Torsten Doenst | Zendy; Jöerg Hausleiter | Zendy; Marcus Franz | Zendy; Christian Jung | Zendy; Henryk Dreger | Zendy; David M. Leistner | Zendy; Brunilda Alushi | Zendy; Anja Stundl | Zendy; Ulf Landmesser | Zendy; Volkmar Falk | Zendy; Karl Stangl | Zendy; Michael Laule | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Interventional Treatment of Severe Tricuspid Regurgitation

Author(s) -

Alexander Lauten,

Hans R. Figulla,

Axel Unbehaun,

Neil Fam,

Joachim Schöfer,

Torsten Doenst,

Jöerg Hausleiter,

Marcus Franz,

Christian Jung,

Henryk Dreger,

David M. Leistner,

Brunilda Alushi,

Anja Stundl,

Ulf Landmesser,

Volkmar Falk,

Karl Stangl,

Michael Laule

Publication year - 2018

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.621

H-Index - 95

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.117.006061

Subject(s) - medicine , surgery , inferior vena cava , regurgitation (circulation) , tricuspid valve , catheter , tricuspid valve insufficiency

Caval valve implantation for the treatment of severe TR and advanced right ventricular failure is associated with a high procedural success rate and seems safe and feasible in an excessive-risk cohort. The study demonstrates hemodynamic efficacy with consistent elimination of TR-associated venous backflow and initial clinical improvement. These results encourage further trials to determine which patients benefit most from this interventional approach.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research